Parkland’s board commissioned a consulting firm to conduct a $150,000 study on executive compensation. The study was completed in April and presented during an executive board meeting in May, according to the report. But when The Dallas Morning News requested a copy of the report July 9, Parkland’s legal team refused.
Parkland wrote a letter to the Texas Attorney General’s Office in late July, arguing that it was trying to implement a “customized compensation plan” to attract, recruit and retain “qualified key employees,” according to the report. Parkland’s senior attorney, Thao La, JD, said making the “sensitive information” public would “substantially” harm the hospital, the greatest risk being competitors trying to recruit Parkland’s executives based on information in the compensation report.
A county commissioner cited in the report also requested a copy of the compensation study but did not receive it.
Joseph Larsen, JD, an attorney representing The Dallas Morning News in open records issues, said the hospital’s argument to withhold the report is not applicable, since a government entity funded the study. Mr. Larsen also said Parkland’s primary purpose in writing to the attorney general “appears to be to delay release of the report,” according to the report.
More Articles on Parkland Memorial Hospital:
Parkland Memorial Hospital May Reinstate Incentives for Execs
DOJ OKs Parkland Memorial’s $1.4M Settlement for Overbilling Allegations
Parkland Memorial Hospital in Dallas to Hire Chief Diversity Officer
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
